EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prothrombotic Tendency in the Shadow of Cancer: Hypercoagulability, Impaired Clot Contraction and Fibrinolysis in Colorectal Cancer and Gastric Cancer Patients Undergoing Chemotherapy

Karolina Aleksandrowicz, Tomasz Rusak iD, Elżbieta Bołtromiuk, Tomasz Misztal iD, Barbara Polityńska-Lewko, Anna M Wojtukiewicz, Joanna Kruszewska, Marta Myśliwiec, Marek Z Wojtukiewicz

International Journal of Molecular Sciences · 21.02.2026 · 27 (4) · 2037

DOI: 10.3390/ijms27042037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.02.2026. Verfasst von Karolina Aleksandrowicz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Waszyngtona 15 B, 15-269 Bialystok, Poland. Hauptthemen laut MEDLINE: Fibrinolysis, Thrombophilia, Colorectal Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is frequently accompanied by thrombotic complications, but conventional coagulation tests often fail to adequately detect cancer-associated hypercoagulability. In this study, blood from 34 patients with colorectal or gastric cancers (before, during and after 3 months of chemotherapy) and 21 healthy controls was analyzed to obtain a coagulation–fibrinolysis profile (by thromboelastometry) and determine the kinetics of clot contraction (CCR). Patients demonstrated hypercoagulable profiles characterized by shortened clotting time, enhanced clot strength, reduced CCR, and impaired fibrinolysis compared to healthy controls, which was more pronounced in colorectal cancer patients. Parameters related to increased clot formation, impaired CC and delayed fibrinolysis correlated with disease stage. Chemotherapy meaningfully prolonged fibrinolysis, which was further evident in vitro with platinum-based drugs. Our findings reveal, for the first time, a significant inhibition of CCR in cancer patients. Integrating thromboelastometry with CCR measurements may improve stratification of cancer-associated thrombotic risk, which appears to arise from the hemostatic disturbances identified in our study. These may extend the duration of clot presence due to reduced fibrinolysis, while decreasing clot stability through diminished CCR. Therefore, careful monitoring of the precarious balance between thrombotic and bleeding tendencies may hold important implications for the fate of cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrinolysisThrombophiliaColorectal NeoplasmsStomach NeoplasmsThrombosisHumansFemaleMaleMiddle AgedThrombelastographyAgedBlood CoagulationBlood Coagulation TestsAdultCase-Control StudiesAntineoplastic Agents

Stichwörter der Autor:innen

cancerchemotherapyclot contractionfibrinolysishypercoagulability

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Waszyngtona 15 B, 15-269 Bialystok, Poland.
  • Bialystok Oncology Center, Ogrodowa 12, 15-022 Bialystok, Poland.
  • Department of Physical Chemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222 Bialystok, Poland.
  • Department of Psychology and Philosophy, Medical University of Bialystok, Szpitalna 37, 15-295 Bialystok, Poland.
  • Department of Oncology, Medical University of Bialystok, Ogrodowa 12, 15-269 Bialystok, Poland.

ORCID-Profile: Tomasz Rusak, Tomasz Misztal

Förderung

  • Medical University of Bialystok

Zitieren

APA

Aleksandrowicz, K., Rusak, T., Bołtromiuk, E., Misztal, T., Polityńska-Lewko, B., Wojtukiewicz, A. M., Kruszewska, J., Myśliwiec, M., & Wojtukiewicz, M. Z. (2026). Prothrombotic Tendency in the Shadow of Cancer: Hypercoagulability, Impaired Clot Contraction and Fibrinolysis in Colorectal Cancer and Gastric Cancer Patients Undergoing Chemotherapy. International Journal of Molecular Sciences, 27(4), 2037. https://doi.org/10.3390/ijms27042037

Vancouver

Aleksandrowicz K, Rusak T, Bołtromiuk E, Misztal T, Polityńska-Lewko B, Wojtukiewicz AM, et al. Prothrombotic Tendency in the Shadow of Cancer: Hypercoagulability, Impaired Clot Contraction and Fibrinolysis in Colorectal Cancer and Gastric Cancer Patients Undergoing Chemotherapy. International Journal of Molecular Sciences. 2026;27(4):2037. doi:10.3390/ijms27042037

BibTeX
@article{Aleksandrowicz2026,
  author = {Aleksandrowicz, Karolina and Rusak, Tomasz and Bołtromiuk, Elżbieta and Misztal, Tomasz and Polityńska-Lewko, Barbara and Wojtukiewicz, Anna M and Kruszewska, Joanna and Myśliwiec, Marta and Wojtukiewicz, Marek Z},
  title = {Prothrombotic Tendency in the Shadow of Cancer: Hypercoagulability, Impaired Clot Contraction and Fibrinolysis in Colorectal Cancer and Gastric Cancer Patients Undergoing Chemotherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {4},
  pages = {2037},
  doi = {10.3390/ijms27042037}
}
Kostenlos starten →